{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T17:05:56Z","timestamp":1789146356638,"version":"build-2803163510"},"reference-count":206,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.intimp.2026.117238","type":"journal-article","created":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T15:50:20Z","timestamp":1786377020000},"page":"117238","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["The gut-kidney axis revisited: Integrating gut microbiota, autophagy and metabolomics in chronic kidney disease"],"prefix":"10.1016","volume":"187","author":[{"given":"Khemender","family":"Lidoo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rupinder","family":"Kaur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ravinder","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarita","family":"Jangra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thakur Gurjeet","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pratima","family":"Kumari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.intimp.2026.117238_bb0005","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.kisu.2021.11.003","article-title":"Epidemiology of chronic kidney disease: an update 2022","volume":"12","author":"Kovesdy","year":"2022","journal-title":"Kidney Int. Suppl. (2011)"},{"key":"10.1016\/j.intimp.2026.117238_bb0010","doi-asserted-by":"crossref","first-page":"1101068","DOI":"10.3389\/fphar.2023.1101068","article-title":"Renin-angiotensin-aldosterone pathway modulators in chronic kidney disease: a comparative review","volume":"14","author":"Alshahrani","year":"2023","journal-title":"Front. Pharmacol."},{"issue":"12","key":"10.1016\/j.intimp.2026.117238_bb0015","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1093\/ndt\/gfv364","article-title":"The application of multi-omics and systems biology to identify therapeutic targets in chronic kidney disease","volume":"31","author":"Cisek","year":"2016","journal-title":"Nephrol. Dial. Transplant."},{"issue":"5","key":"10.1016\/j.intimp.2026.117238_bb0020","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1038\/s41581-025-00934-5","article-title":"Advances and challenges in kidney fibrosis therapeutics","volume":"21","author":"Abbad","year":"2025","journal-title":"Nat. Rev. Nephrol."},{"issue":"4","key":"10.1016\/j.intimp.2026.117238_bb0025","doi-asserted-by":"crossref","first-page":"e24","DOI":"10.1097\/IMNA-D-24-00027","article-title":"Kidney fibrosis: fundamental questions, challenges, and perspectives","volume":"11","author":"Liu","year":"2024","journal-title":"Integrative Medicine in Nephrology and Andrology"},{"key":"10.1016\/j.intimp.2026.117238_bb0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbi.2025.111784","article-title":"Oxidative stress and inflammation in renal fibrosis: novel molecular mechanisms and therapeutic targets","volume":"421","author":"Liu","year":"2025","journal-title":"Chem. Biol. Interact."},{"issue":"4","key":"10.1016\/j.intimp.2026.117238_bb0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.ctmp.2025.200245","article-title":"Total Panax notoginseng saponins treats diabetic kidney disease in mice by regulating the TXNIP\/NLRP3 signaling pathway","volume":"6","author":"Gao","year":"2025","journal-title":"Clinical Traditional Medicine and Pharmacology"},{"issue":"1","key":"10.1016\/j.intimp.2026.117238_bb0040","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1038\/s41401-023-01148-w","article-title":"Sirtuin 6 protects against podocyte injury by blocking the renin-angiotensin system by inhibiting the Wnt1\/\u03b2-catenin pathway","volume":"45","author":"Miao","year":"2024","journal-title":"Acta Pharmacol. Sin."},{"issue":"6","key":"10.1016\/j.intimp.2026.117238_bb0045","doi-asserted-by":"crossref","DOI":"10.3390\/biom15060794","article-title":"Mechanisms of acute kidney injury-chronic kidney disease transition: unraveling maladaptive repair and therapeutic opportunities","volume":"15","author":"Xu","year":"2025","journal-title":"Biomolecules"},{"issue":"6","key":"10.1016\/j.intimp.2026.117238_bb0050","doi-asserted-by":"crossref","DOI":"10.1016\/j.semnephrol.2025.151584","article-title":"Multi-omics integration in nephrology: advances, challenges, and future directions","volume":"44","author":"Saliba","year":"2024","journal-title":"Semin. Nephrol."},{"issue":"1","key":"10.1016\/j.intimp.2026.117238_bb0055","doi-asserted-by":"crossref","DOI":"10.3390\/diagnostics15010021","article-title":"The gut-kidney axis in chronic kidney diseases","volume":"15","author":"Tsuji","year":"2024","journal-title":"Diagnostics"},{"issue":"1","key":"10.1016\/j.intimp.2026.117238_bb0060","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21010263","article-title":"Inflammation and oxidative stress in chronic kidney disease-potential therapeutic role of minerals, vitamins and plant-derived metabolites","volume":"21","author":"Rapa","year":"2019","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.intimp.2026.117238_bb0065","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1007\/s10059-013-0140-8","article-title":"Autophagy: a critical regulator of cellular metabolism and homeostasis","volume":"36","author":"Ryter","year":"2013","journal-title":"Mol. Cell"},{"issue":"3","key":"10.1016\/j.intimp.2026.117238_bb0070","doi-asserted-by":"crossref","DOI":"10.3390\/cells12030412","article-title":"Autophagy as a therapeutic target for chronic kidney disease and the roles of TGF-\u03b21 in autophagy and kidney fibrosis","volume":"12","author":"Ruby","year":"2023","journal-title":"Cells"},{"key":"10.1016\/j.intimp.2026.117238_bb0075","article-title":"Pharmacological potential of Chinese botanical drugs in managing chronic kidney disease by targeting mitochondrial quality control","volume":"16","author":"Liu","year":"2025","journal-title":"Front. Pharmacol."},{"issue":"1","key":"10.1016\/j.intimp.2026.117238_bb0080","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1186\/s10020-023-00745-z","article-title":"The potential mechanism of gut microbiota-microbial metabolites-mitochondrial axis in progression of diabetic kidney disease","volume":"29","author":"Ma","year":"2023","journal-title":"Mol. Med."},{"issue":"2","key":"10.1016\/j.intimp.2026.117238_bb0085","doi-asserted-by":"crossref","first-page":"194","DOI":"10.3390\/metabo12020194","article-title":"The potential of metabolomics in biomedical applications","volume":"12","author":"Gonzalez-Covarrubias","year":"2022","journal-title":"Metabolites"},{"issue":"2","key":"10.1016\/j.intimp.2026.117238_bb0090","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.ekir.2024.10.035","article-title":"The role of mitochondria in diabetic kidney disease and potential therapeutic targets","volume":"10","author":"Takasu","year":"2025","journal-title":"Kidney Int Rep"},{"issue":"6","key":"10.1016\/j.intimp.2026.117238_bb0095","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1007\/s00467-016-3392-7","article-title":"Gut microbiome and kidney disease: a bidirectional relationship","volume":"32","author":"Al Khodor","year":"2017","journal-title":"Pediatr. Nephrol."},{"issue":"3","key":"10.1016\/j.intimp.2026.117238_bb0100","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0283389","article-title":"Changes in gut microbial community upon chronic kidney disease","volume":"18","author":"Liu","year":"2023","journal-title":"PLoS One"},{"issue":"8","key":"10.1016\/j.intimp.2026.117238_bb0105","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2023.e18991","article-title":"Chronic kidney disease and gut microbiota","volume":"9","author":"Amini Khiabani","year":"2023","journal-title":"Heliyon"},{"issue":"9","key":"10.1016\/j.intimp.2026.117238_bb0110","doi-asserted-by":"crossref","DOI":"10.3390\/nu15092211","article-title":"Short-chain fatty-acid-producing Bacteria: key components of the human gut microbiota","volume":"15","author":"Fusco","year":"2023","journal-title":"Nutrients"},{"issue":"1","key":"10.1016\/j.intimp.2026.117238_bb0115","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00394-017-1445-8","article-title":"Gut microbiota functions: metabolism of nutrients and other food components","volume":"57","author":"Rowland","year":"2018","journal-title":"Eur. J. Nutr."},{"issue":"6","key":"10.1016\/j.intimp.2026.117238_bb0120","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1080\/00325481.2020.1744335","article-title":"Characterizing the gut microbiota in patients with chronic kidney disease","volume":"132","author":"Hu","year":"2020","journal-title":"Postgrad. Med."},{"issue":"4","key":"10.1016\/j.intimp.2026.117238_bb0125","doi-asserted-by":"crossref","DOI":"10.3390\/nu13041273","article-title":"Phosphate, microbiota and CKD","volume":"13","author":"Favero","year":"2021","journal-title":"Nutrients"},{"issue":"1","key":"10.1016\/j.intimp.2026.117238_bb0130","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000345969","article-title":"Role of urea in intestinal barrier dysfunction and disruption of epithelial tight junction in chronic kidney disease","volume":"37","author":"Vaziri","year":"2013","journal-title":"Am. J. Nephrol."},{"issue":"10","key":"10.1016\/j.intimp.2026.117238_bb0135","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1038\/s41581-025-00988-5","article-title":"Microbiota and kidney disease: the road ahead","volume":"21","author":"Bloom","year":"2025","journal-title":"Nat. Rev. Nephrol."},{"issue":"3","key":"10.1016\/j.intimp.2026.117238_bb0140","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.7150\/ijbs.124499","article-title":"Microbiota-gut-kidney Axis and targeted therapeutic strategies in kidney diseases","volume":"22","author":"Sun","year":"2026","journal-title":"Int. J. Biol. Sci."},{"issue":"2","key":"10.1016\/j.intimp.2026.117238_bb0145","doi-asserted-by":"crossref","first-page":"750","DOI":"10.7150\/ijbs.125140","article-title":"Microbiota-gut-kidney axis in health and renal disease","volume":"22","author":"Jin","year":"2026","journal-title":"Int. J. Biol. Sci."},{"issue":"4","key":"10.1016\/j.intimp.2026.117238_bb0150","doi-asserted-by":"crossref","first-page":"e24","DOI":"10.1097\/IMNA-D-25-00007","article-title":"Gut microbiota and membranous nephropathy: novel molecular mechanisms and natural product therapeutic strategies","volume":"12","author":"Zhao","year":"2025","journal-title":"Integrative Medicine in Nephrology and Andrology"},{"issue":"3","key":"10.1016\/j.intimp.2026.117238_bb0155","doi-asserted-by":"crossref","first-page":"e25","DOI":"10.1097\/IMNA-D-25-00026","article-title":"Targeting gut microbiota as a promising therapy for chronic kidney disease","volume":"12","author":"He","year":"2025","journal-title":"Integrative Medicine in Nephrology and Andrology"},{"issue":"1","key":"10.1016\/j.intimp.2026.117238_bb0160","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1186\/s13059-023-03056-y","article-title":"Metagenome-wide analysis uncovers gut microbial signatures and implicates taxon-specific functions in end-stage renal disease","volume":"24","author":"Zhang","year":"2023","journal-title":"Genome Biol."},{"issue":"1","key":"10.1016\/j.intimp.2026.117238_bb0165","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/19490976.2021.1897212","article-title":"The role of short-chain fatty acids in the interplay between gut microbiota and diet in cardio-metabolic health","volume":"13","author":"Nogal","year":"2021","journal-title":"Gut Microbes"},{"issue":"3","key":"10.1016\/j.intimp.2026.117238_bb0170","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1080\/19490976.2015.1134082","article-title":"Formation of short chain fatty acids by the gut microbiota and their impact on human metabolism","volume":"7","author":"Morrison","year":"2016","journal-title":"Gut Microbes"},{"issue":"12","key":"10.1016\/j.intimp.2026.117238_bb0175","doi-asserted-by":"crossref","first-page":"2232","DOI":"10.1136\/gutjnl-2020-322260","article-title":"Mucus barrier, mucins and gut microbiota: the expected slimy partners?","volume":"69","author":"Paone","year":"2020","journal-title":"Gut"},{"issue":"2","key":"10.1016\/j.intimp.2026.117238_bb0180","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.bbrc.2017.03.071","article-title":"Short-chain fatty acids, GPR41 and GPR43 ligands, inhibit TNF-\u03b1-induced MCP-1 expression by modulating p38 and JNK signaling pathways in human renal cortical epithelial cells","volume":"486","author":"Kobayashi","year":"2017","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"1","key":"10.1016\/j.intimp.2026.117238_bb0185","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1186\/s12967-024-04974-6","article-title":"Gut microbial metabolites SCFAs and chronic kidney disease","volume":"22","author":"He","year":"2024","journal-title":"J. Transl. Med."},{"issue":"1","key":"10.1016\/j.intimp.2026.117238_bb0190","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1093\/ndt\/gfae118","article-title":"Propionate and butyrate counteract renal damage and progression to chronic kidney disease","volume":"40","author":"Corte-Iglesias","year":"2024","journal-title":"Nephrol. Dial. Transplant."},{"issue":"21","key":"10.1016\/j.intimp.2026.117238_bb0195","doi-asserted-by":"crossref","DOI":"10.3390\/ijms262110706","article-title":"Gut microbiome in patients with chronic kidney disease stages 4 and 5: a systematic literature review","volume":"26","author":"Suliman","year":"2025","journal-title":"Int. J. Mol. Sci."},{"issue":"17","key":"10.1016\/j.intimp.2026.117238_bb0200","doi-asserted-by":"crossref","DOI":"10.3390\/nu17172904","article-title":"Gut microbiome-derived short-chain fatty acids in glomerular protection and modulation of chronic kidney disease progression","volume":"17","author":"Szrejder","year":"2025","journal-title":"Nutrients"},{"issue":"3","key":"10.1016\/j.intimp.2026.117238_bb0205","doi-asserted-by":"crossref","first-page":"432","DOI":"10.3803\/EnM.2021.1336","article-title":"Short-chain fatty acids attenuate renal fibrosis and enhance autophagy of renal tubular cells in diabetic mice through the HDAC2\/ULK1 Axis","volume":"37","author":"Ma","year":"2022","journal-title":"Endocrinol Metab (Seoul)"},{"issue":"12","key":"10.1016\/j.intimp.2026.117238_bb0210","doi-asserted-by":"crossref","first-page":"5398","DOI":"10.7150\/thno.41725","article-title":"Integrative metagenomic and metabolomic analyses reveal severity-specific signatures of gut microbiota in chronic kidney disease","volume":"10","author":"Wu","year":"2020","journal-title":"Theranostics"},{"issue":"3","key":"10.1016\/j.intimp.2026.117238_bb0215","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1002\/jcla.20456","article-title":"P-Cresylsulfate and indoxyl sulfate level at different stages of chronic kidney disease","volume":"25","author":"Lin","year":"2011","journal-title":"J. Clin. Lab. Anal."},{"issue":"3","key":"10.1016\/j.intimp.2026.117238_bb0220","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1053\/j.ajkd.2015.09.027","article-title":"Role of the gut microbiome in uremia: a potential therapeutic target","volume":"67","author":"Ramezani","year":"2016","journal-title":"Am. J. Kidney Dis."},{"issue":"10","key":"10.1016\/j.intimp.2026.117238_bb0225","doi-asserted-by":"crossref","DOI":"10.3390\/nu13103637","article-title":"A link between chronic kidney disease and gut microbiota in immunological and nutritional aspects","volume":"13","author":"Mertowska","year":"2021","journal-title":"Nutrients"},{"issue":"1","key":"10.1016\/j.intimp.2026.117238_bb0230","doi-asserted-by":"crossref","first-page":"2226","DOI":"10.1038\/s41467-024-46481-8","article-title":"Inhibition of urease-mediated ammonia production by 2-octynohydroxamic acid in hepatic encephalopathy","volume":"15","author":"Evstafeva","year":"2024","journal-title":"Nat. Commun."},{"issue":"4","key":"10.1016\/j.intimp.2026.117238_bb0235","doi-asserted-by":"crossref","DOI":"10.3390\/toxins13040252","article-title":"The impact of CKD on uremic toxins and gut microbiota","volume":"13","author":"Rysz","year":"2021","journal-title":"Toxins (Basel)"},{"key":"10.1016\/j.intimp.2026.117238_bb0240","doi-asserted-by":"crossref","first-page":"217","DOI":"10.3389\/fphys.2012.00217","article-title":"Urea transporter physiology studied in knockout mice","volume":"3","author":"Li","year":"2012","journal-title":"Front. Physiol."},{"issue":"7","key":"10.1016\/j.intimp.2026.117238_bb0245","doi-asserted-by":"crossref","first-page":"2841","DOI":"10.1172\/JCI79214","article-title":"Engineering the gut microbiota to treat hyperammonemia","volume":"125","author":"Shen","year":"2015","journal-title":"J. Clin. Invest."},{"issue":"1","key":"10.1016\/j.intimp.2026.117238_bb0250","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.nefroe.2017.01.017","article-title":"Gut microbiota in chronic kidney disease","volume":"37","author":"Guldris","year":"2017","journal-title":"Nefrolog\u00eda (English Edition)"},{"issue":"3","key":"10.1016\/j.intimp.2026.117238_bb0255","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1093\/advances\/nmz127","article-title":"Tryptophan metabolism: a link between the gut microbiota and brain","volume":"11","author":"Gao","year":"2020","journal-title":"Adv. Nutr."},{"issue":"2","key":"10.1016\/j.intimp.2026.117238_bb0260","doi-asserted-by":"crossref","DOI":"10.3390\/toxins9020052","article-title":"P-Cresyl sulfate","volume":"9","author":"Gryp","year":"2017","journal-title":"Toxins (Basel)"},{"issue":"4","key":"10.1016\/j.intimp.2026.117238_bb0265","doi-asserted-by":"crossref","DOI":"10.3390\/metabo15040220","article-title":"Trimethylamine-N-oxide (TMAO) as a rising-star metabolite: implications for human health","volume":"15","author":"Caradonna","year":"2025","journal-title":"Metabolites"},{"issue":"1","key":"10.1016\/j.intimp.2026.117238_bb0270","doi-asserted-by":"crossref","DOI":"10.1530\/MAH-24-0012","article-title":"Chronic kidney disease, uremic toxins and microbiota","volume":"3","author":"Rumanli","year":"2025","journal-title":"Microbiota and Host"},{"key":"10.1016\/j.intimp.2026.117238_bb0275","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1053\/j.ajkd.2004.04.033","article-title":"Removal of the protein-bound solute p-cresol by convective transport: a randomized crossover study","volume":"44","author":"Bammens","year":"2004","journal-title":"Am. J. Kidney Dis."},{"issue":"11","key":"10.1016\/j.intimp.2026.117238_bb0280","doi-asserted-by":"crossref","DOI":"10.3390\/toxins11110635","article-title":"Elevation of trimethylamine-N-oxide in chronic kidney disease: contribution of decreased glomerular filtration rate","volume":"11","author":"Pelletier","year":"2019","journal-title":"Toxins (Basel)"},{"issue":"1","key":"10.1016\/j.intimp.2026.117238_bb0285","doi-asserted-by":"crossref","DOI":"10.3390\/toxins18010057","article-title":"Strategies for removal of protein-bound uremic toxins in hemodialysis","volume":"18","author":"de Vries","year":"2026","journal-title":"Toxins (Basel)"},{"issue":"3","key":"10.1016\/j.intimp.2026.117238_bb0290","doi-asserted-by":"crossref","DOI":"10.1097\/IMNA-D-24-00002","article-title":"A possible role of P-cresyl sulfate and indoxyl sulfate as biomarkers in the prediction of renal function according to the GFR (G) categories","volume":"11","author":"Corradi","year":"2024","journal-title":"Integr. Med. Nephrol. Androl."},{"key":"10.1016\/j.intimp.2026.117238_bb0295","doi-asserted-by":"crossref","first-page":"2023","DOI":"10.1038\/s41401-026-01801-0","article-title":"Gut microbiota and renal fibrosis: novel mechanistic insights and therapeutic potential","volume":"47","author":"Liu","year":"2026","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.intimp.2026.117238_bb0300","doi-asserted-by":"crossref","DOI":"10.1016\/j.fct.2024.114917","article-title":"Indole-3-acetic acid exposure leads to cardiovascular inflammation and fibrosis in chronic kidney disease rat model","volume":"192","author":"Nayak","year":"2024","journal-title":"Food Chem. Toxicol."},{"issue":"5","key":"10.1016\/j.intimp.2026.117238_bb0305","doi-asserted-by":"crossref","first-page":"359","DOI":"10.4103\/ijn.IJN_71_17","article-title":"Role of gut-derived uremic toxins on oxidative stress and inflammation in patients with chronic kidney disease","volume":"27","author":"Gouroju","year":"2017","journal-title":"Indian J. Nephrol."},{"issue":"1","key":"10.1016\/j.intimp.2026.117238_bb0310","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23010531","article-title":"Impact of uremic toxins on endothelial dysfunction in chronic kidney disease: a systematic review","volume":"23","author":"Harlacher","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"23","key":"10.1016\/j.intimp.2026.117238_bb0315","doi-asserted-by":"crossref","first-page":"7149","DOI":"10.3390\/jcm13237149","article-title":"Role of uremic toxins in vascular inflammation associated with chronic kidney disease","volume":"13","author":"Chermiti","year":"2024","journal-title":"J. Clin. Med."},{"issue":"4","key":"10.1016\/j.intimp.2026.117238_bb0320","doi-asserted-by":"crossref","first-page":"280","DOI":"10.3390\/toxins14040280","article-title":"Uremic toxins and cardiovascular risk in chronic kidney disease: what have we learned recently beyond the past findings?","volume":"14","author":"El Chamieh","year":"2022","journal-title":"Toxins"},{"issue":"10","key":"10.1016\/j.intimp.2026.117238_bb0325","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.2215\/CJN.03980609","article-title":"Serum indoxyl sulfate is associated with vascular disease and mortality in chronic kidney disease patients","volume":"4","author":"Barreto","year":"2009","journal-title":"Clin. J. Am. Soc. Nephrol."},{"issue":"4","key":"10.1016\/j.intimp.2026.117238_bb0330","doi-asserted-by":"crossref","DOI":"10.3892\/ijmm.2025.5603","article-title":"Role of the TGF-\u03b2\/Smad signaling pathway in the transition from acute kidney injury to chronic kidney disease (review)","volume":"56","author":"Zou","year":"2025","journal-title":"Int. J. Mol. Med."},{"issue":"4","key":"10.1016\/j.intimp.2026.117238_bb0335","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.bcp.2009.04.017","article-title":"Renal organic anion transporters OAT1 and OAT3 mediate the cellular accumulation of 5-sulfooxymethylfurfural, a reactive, nephrotoxic metabolite of the Maillard product 5-hydroxymethylfurfural","volume":"78","author":"Bakhiya","year":"2009","journal-title":"Biochem. Pharmacol."},{"issue":"1","key":"10.1016\/j.intimp.2026.117238_bb0340","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1038\/s41392-024-01913-1","article-title":"Targeting lactobacillus johnsonii to reverse chronic kidney disease","volume":"9","author":"Miao","year":"2024","journal-title":"Signal Transduct. Target. Ther."},{"issue":"10","key":"10.1016\/j.intimp.2026.117238_bb0345","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2024.114830","article-title":"Gut Bacteroides ovatus ameliorates renal fibrosis by promoting the production of HDCA through upregulation of Clostridium scindens","volume":"43","author":"Si","year":"2024","journal-title":"Cell Rep."},{"issue":"4","key":"10.1016\/j.intimp.2026.117238_bb0350","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1093\/advances\/nmab149","article-title":"Effects of microbiota-driven therapy on circulating Indoxyl sulfate and P-Cresyl sulfate in patients with chronic kidney disease: a systematic review and Meta-analysis of randomized controlled trials","volume":"13","author":"Chen","year":"2022","journal-title":"Adv. Nutr."},{"key":"10.1016\/j.intimp.2026.117238_bb0355","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1124704","article-title":"Gut microbiota and its metabolites - molecular mechanisms and management strategies in diabetic kidney disease","volume":"14","author":"Mao","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.intimp.2026.117238_bb0360","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2021.682482","article-title":"Trimethylamine N-oxide exacerbates renal inflammation and fibrosis in rats with diabetic kidney disease","volume":"12","author":"Fang","year":"2021","journal-title":"Front. Physiol."},{"key":"10.1016\/j.intimp.2026.117238_bb0365","article-title":"Gut microbiota dysbiosis in diabetic nephropathy: mechanisms and therapeutic targeting via the gut-kidney axis","volume":"16-2025","author":"Jiang","year":"2025","journal-title":"Front. Endocrinol."},{"issue":"4","key":"10.1016\/j.intimp.2026.117238_bb0370","doi-asserted-by":"crossref","DOI":"10.3390\/toxins12040229","article-title":"Indoxyl sulfate, a uremic endotheliotoxin","volume":"12","author":"Lano","year":"2020","journal-title":"Toxins (Basel)"},{"issue":"6","key":"10.1016\/j.intimp.2026.117238_bb0375","article-title":"Indoxyl-sulfate-induced redox imbalance in chronic kidney disease","volume":"10","author":"Lu","year":"2021","journal-title":"Antioxidants (Basel)"},{"issue":"3","key":"10.1016\/j.intimp.2026.117238_bb0380","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0091517","article-title":"Indoxyl sulfate downregulates expression of mas receptor via OAT3\/AhR\/Stat3 pathway in proximal tubular cells","volume":"9","author":"Ng","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.intimp.2026.117238_bb0385","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2022.904401","article-title":"Gut microbiome characteristics in IgA nephropathy: qualitative and quantitative analysis from observational studies","volume":"12","author":"Han","year":"2022","journal-title":"Front. Cell. Infect. Microbiol."},{"issue":"1","key":"10.1016\/j.intimp.2026.117238_bb0390","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/s00467-017-3652-1","article-title":"The gut-kidney axis in IgA nephropathy: role of microbiota and diet on genetic predisposition","volume":"33","author":"Coppo","year":"2018","journal-title":"Pediatr. Nephrol."},{"key":"10.1016\/j.intimp.2026.117238_bb0395","article-title":"The dysbiosis of gut microbiota and dysregulation of metabolites in IgA nephropathy and membranous nephropathy","volume":"12","author":"Zhang","year":"2025","journal-title":"Front Med (Lausanne)"},{"issue":"1","key":"10.1016\/j.intimp.2026.117238_bb0400","doi-asserted-by":"crossref","DOI":"10.1080\/19490976.2025.2458184","article-title":"Targeted modulation of intestinal barrier and mucosal immune-related microbiota attenuates IgA nephropathy progression","volume":"17","author":"Zhang","year":"2025","journal-title":"Gut Microbes"},{"issue":"8","key":"10.1016\/j.intimp.2026.117238_bb0405","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0134311","article-title":"Gut-microbiota-metabolite Axis in early renal function decline","volume":"10","author":"Barrios","year":"2015","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.intimp.2026.117238_bb0410","doi-asserted-by":"crossref","first-page":"420","DOI":"10.7150\/ijbs.37421","article-title":"Gut microbiota as diagnostic tools for mirroring disease progression and circulating Nephrotoxin levels in chronic kidney disease: discovery and validation study","volume":"16","author":"Wu","year":"2020","journal-title":"Int. J. Biol. Sci."},{"issue":"1","key":"10.1016\/j.intimp.2026.117238_bb0415","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/s40168-022-01443-4","article-title":"Perturbed gut microbiome and fecal and serum metabolomes are associated with chronic kidney disease severity","volume":"11","author":"Wang","year":"2023","journal-title":"Microbiome"},{"issue":"1","key":"10.1016\/j.intimp.2026.117238_bb0420","doi-asserted-by":"crossref","DOI":"10.3390\/cells8010061","article-title":"Autophagy in chronic kidney diseases","volume":"8","author":"Lin","year":"2019","journal-title":"Cells"},{"issue":"1","key":"10.1016\/j.intimp.2026.117238_bb0425","article-title":"Autophagy in kidney physiology: from cellular quality control to organ metabolism","volume":"5","author":"Yamamoto","year":"2026","journal-title":"Autophagy Rep."},{"issue":"4","key":"10.1016\/j.intimp.2026.117238_bb0430","doi-asserted-by":"crossref","DOI":"10.3390\/life13040957","article-title":"Gut microbiota in autophagy regulation: new therapeutic perspective in neurodegeneration","volume":"13","author":"Mitra","year":"2023","journal-title":"Life"},{"issue":"1","key":"10.1016\/j.intimp.2026.117238_bb0435","doi-asserted-by":"crossref","DOI":"10.1186\/s12993-022-00187-3","article-title":"The interplay between oxidative stress and autophagy: focus on the development of neurological diseases","volume":"18","author":"Talebi","year":"2022","journal-title":"Behav. Brain Funct."},{"issue":"51","key":"10.1016\/j.intimp.2026.117238_bb0440","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000040975","article-title":"Research progress on the mechanism of hyperuricemic nephropathy based on multi-omics technique: a review","volume":"103","author":"Li","year":"2024","journal-title":"Medicine"},{"issue":"6","key":"10.1016\/j.intimp.2026.117238_bb0445","doi-asserted-by":"crossref","first-page":"F877","DOI":"10.1152\/ajprenal.00415.2023","article-title":"Mechanisms and implications of podocyte autophagy in chronic kidney disease","volume":"326","author":"Njeim","year":"2024","journal-title":"American Journal of Physiology-Renal Physiology"},{"issue":"1","key":"10.1016\/j.intimp.2026.117238_bb0450","doi-asserted-by":"crossref","first-page":"2994","DOI":"10.1038\/s41467-023-38401-z","article-title":"Redefining the role of AMPK in autophagy and the energy stress response","volume":"14","author":"Park","year":"2023","journal-title":"Nat. Commun."},{"issue":"7","key":"10.1016\/j.intimp.2026.117238_bb0455","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1161\/RES.0b013e3182194c29","article-title":"AMPK activates autophagy by phosphorylating ULK1","volume":"108","author":"Mao","year":"2011","journal-title":"Circ. Res."},{"issue":"6","key":"10.1016\/j.intimp.2026.117238_bb0460","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1038\/s41419-024-06833-0","article-title":"Mitochondrial metabolic reprogramming in diabetic kidney disease","volume":"15","author":"Fan","year":"2024","journal-title":"Cell Death Dis."},{"issue":"21","key":"10.1016\/j.intimp.2026.117238_bb0465","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21217994","article-title":"Critical role for AMPK in metabolic disease-induced chronic kidney disease","volume":"21","author":"Juszczak","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"10","key":"10.1016\/j.intimp.2026.117238_bb0470","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1096\/fba.2023-00045","article-title":"A combination of 5\/6-nephrectomy and unilateral ureteral obstruction model accelerates progression of remote organ fibrosis in chronic kidney disease","volume":"5","author":"Homma","year":"2023","journal-title":"FASEB Bioadv"},{"issue":"6","key":"10.1016\/j.intimp.2026.117238_bb0475","doi-asserted-by":"crossref","first-page":"763","DOI":"10.4239\/wjd.v5.i6.763","article-title":"Biomarkers in diabetic nephropathy: present and future","volume":"5","author":"Currie","year":"2014","journal-title":"World J. Diabetes"},{"issue":"4","key":"10.1016\/j.intimp.2026.117238_bb0480","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1038\/cdd.2010.117","article-title":"Short-chain fatty acids induced autophagy serves as an adaptive strategy for retarding mitochondria-mediated apoptotic cell death","volume":"18","author":"Tang","year":"2011","journal-title":"Cell Death Differ."},{"issue":"11","key":"10.1016\/j.intimp.2026.117238_bb0485","doi-asserted-by":"crossref","DOI":"10.1111\/cns.70657","article-title":"AMPK\/SIRT1\/PGC-1\u03b1 signaling pathway: molecular mechanisms and targeted strategies from energy homeostasis regulation to disease therapy","volume":"31","author":"Chen","year":"2025","journal-title":"CNS Neurosci. Ther."},{"issue":"1","key":"10.1016\/j.intimp.2026.117238_bb0490","doi-asserted-by":"crossref","DOI":"10.1080\/0886022X.2024.2336128","article-title":"Adenine-induced animal model of chronic kidney disease: current applications and future perspectives","volume":"46","author":"Yang","year":"2024","journal-title":"Ren. Fail."},{"issue":"9","key":"10.1016\/j.intimp.2026.117238_bb0495","doi-asserted-by":"crossref","DOI":"10.3390\/toxins12090590","article-title":"Gut-derived protein-bound uremic toxins","volume":"12","author":"Graboski","year":"2020","journal-title":"Toxins (Basel)"},{"key":"10.1016\/j.intimp.2026.117238_bb0500","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2026.103036","article-title":"Gut microbiota-derived metabolites as immune modulators in aging and age-related chronic inflammatory diseases","volume":"116","author":"Chen","year":"2026","journal-title":"Ageing Res. Rev."},{"issue":"1","key":"10.1016\/j.intimp.2026.117238_bb0505","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/s43556-022-00108-w","article-title":"Metformin in therapeutic applications in human diseases: its mechanism of action and clinical study","volume":"3","author":"Du","year":"2022","journal-title":"Molecular Biomedicine"},{"key":"10.1016\/j.intimp.2026.117238_bb0510","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1146\/annurev-biochem-061516-044820","article-title":"Mechanisms of autophagy initiation","volume":"86","author":"Hurley","year":"2017","journal-title":"Annu. Rev. Biochem."},{"issue":"7","key":"10.1016\/j.intimp.2026.117238_bb0515","doi-asserted-by":"crossref","DOI":"10.3390\/jcm13071881","article-title":"Fibrosis in chronic kidney disease: pathophysiology and therapeutic targets","volume":"13","author":"Reiss","year":"2024","journal-title":"J. Clin. Med."},{"issue":"1","key":"10.1016\/j.intimp.2026.117238_bb0520","doi-asserted-by":"crossref","first-page":"R15","DOI":"10.1530\/JOE-14-0437","article-title":"Autophagy in diabetic nephropathy","volume":"224","author":"Ding","year":"2015","journal-title":"J. Endocrinol."},{"issue":"17","key":"10.1016\/j.intimp.2026.117238_bb0525","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21176356","article-title":"Short-chain fatty acids and their association with Signalling pathways in inflammation, glucose and lipid metabolism","volume":"21","author":"He","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"3","key":"10.1016\/j.intimp.2026.117238_bb0530","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1089\/ars.2013.5363","article-title":"Autophagy in kidney health and disease","volume":"20","author":"Wang","year":"2014","journal-title":"Antioxid. Redox Signal."},{"issue":"15","key":"10.1016\/j.intimp.2026.117238_bb0535","doi-asserted-by":"crossref","first-page":"2977","DOI":"10.1042\/BCJ20210284","article-title":"Investigation of the specificity and mechanism of action of the ULK1\/AMPK inhibitor SBI-0206965","volume":"478","author":"Ahwazi","year":"2021","journal-title":"Biochem. J."},{"issue":"3","key":"10.1016\/j.intimp.2026.117238_bb0540","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1089\/ars.2013.5371","article-title":"An overview of autophagy: morphology, mechanism, and regulation","volume":"20","author":"Parzych","year":"2014","journal-title":"Antioxid. Redox Signal."},{"issue":"5","key":"10.1016\/j.intimp.2026.117238_bb0545","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21051772","article-title":"PINK1\/Parkin mediated Mitophagy, ca(2+) Signalling, and ER-mitochondria contacts in Parkinson\u2019s disease","volume":"21","author":"Barazzuol","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.intimp.2026.117238_bb0550","doi-asserted-by":"crossref","DOI":"10.3390\/cells12010088","article-title":"Oxidative stress and mitochondrial dysfunction in chronic kidney disease","volume":"12","author":"Ho","year":"2022","journal-title":"Cells"},{"issue":"10","key":"10.1016\/j.intimp.2026.117238_bb0555","doi-asserted-by":"crossref","DOI":"10.3390\/biom14101270","article-title":"Mitophagy in cell death regulation: insights into mechanisms and disease implications","volume":"14","author":"Lin","year":"2024","journal-title":"Biomolecules"},{"key":"10.1016\/j.intimp.2026.117238_bb0560","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2023.121432","article-title":"Mitochondrial dysfunction and oxidative stress: role in chronic kidney disease","volume":"319","author":"Srivastava","year":"2023","journal-title":"Life Sci."},{"issue":"1","key":"10.1016\/j.intimp.2026.117238_bb0565","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.158183","article-title":"Aorta- and liver-generated TMAO enhances trained immunity for increased inflammation via ER stress\/mitochondrial ROS\/glycolysis pathways","volume":"8","author":"Saaoud","year":"2023","journal-title":"JCI Insight"},{"key":"10.1016\/j.intimp.2026.117238_bb0570","article-title":"The role of mitophagy in the development of chronic kidney disease","volume":"12","author":"Yang","year":"2024","journal-title":"PeerJ"},{"issue":"11","key":"10.1016\/j.intimp.2026.117238_bb0575","doi-asserted-by":"crossref","first-page":"2505","DOI":"10.1016\/j.ekir.2022.08.004","article-title":"Kidney biopsy in patients with markedly reduced kidney function","volume":"7","author":"Alkadi","year":"2022","journal-title":"Kidney Int Rep"},{"issue":"1","key":"10.1016\/j.intimp.2026.117238_bb0580","doi-asserted-by":"crossref","DOI":"10.1038\/s41419-021-04469-y","article-title":"BNIP3L\/NIX-mediated mitophagy: molecular mechanisms and implications for human disease","volume":"13","author":"Li","year":"2021","journal-title":"Cell Death Dis."},{"issue":"1","key":"10.1016\/j.intimp.2026.117238_bb0585","doi-asserted-by":"crossref","DOI":"10.2174\/0118741045375825250415073204","article-title":"Urolithins\u2013gut microbial metabolites with potential health benefits","volume":"19","author":"Trapali","year":"2025","journal-title":"The Open Medicinal Chemistry Journal"},{"key":"10.1016\/j.intimp.2026.117238_bb0590","article-title":"Urolithin a attenuates hyperuricemic nephropathy in fructose-fed mice by impairing STING-NLRP3 axis-mediated inflammatory response via restoration of Parkin-dependent mitophagy","volume":"13-2022","author":"Zhang","year":"2022","journal-title":"Front. Pharmacol."},{"issue":"16","key":"10.1016\/j.intimp.2026.117238_bb0595","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22168773","article-title":"The interplay between autophagy and NLRP3 Inflammasome in ischemia\/reperfusion injury","volume":"22","author":"Lv","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.intimp.2026.117238_bb0600","article-title":"Chronic kidney disease and NLRP3 inflammasome: pathogenesis, development and targeted therapeutic strategies","volume":"33","author":"Huang","year":"2023","journal-title":"Biochem. Biophys. Rep."},{"key":"10.1016\/j.intimp.2026.117238_bb0605","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.591803","article-title":"Interplay between NLRP3 Inflammasome and autophagy","volume":"11","author":"Biasizzo","year":"2020","journal-title":"Front. Immunol."},{"issue":"5","key":"10.1016\/j.intimp.2026.117238_bb0610","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/j.molcel.2013.08.003","article-title":"Phosphorylation of p62 activates the Keap1-Nrf2 pathway during selective autophagy","volume":"51","author":"Ichimura","year":"2013","journal-title":"Mol. Cell"},{"issue":"6","key":"10.1016\/j.intimp.2026.117238_bb0615","article-title":"Nrf2 activation in chronic kidney disease: promises and pitfalls","volume":"11","author":"Aranda-Rivera","year":"2022","journal-title":"Antioxidants (Basel, Switzerland)"},{"issue":"5","key":"10.1016\/j.intimp.2026.117238_bb0620","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1038\/s41581-023-00694-0","article-title":"Regulated cell death pathways in kidney disease","volume":"19","author":"Sanz","year":"2023","journal-title":"Nat. Rev. Nephrol."},{"issue":"1","key":"10.1016\/j.intimp.2026.117238_bb0625","doi-asserted-by":"crossref","first-page":"F1","DOI":"10.1152\/ajprenal.00012.2023","article-title":"Autophagy and mitophagy: physiological implications in kidney inflammation and diseases","volume":"325","author":"Bhatia","year":"2023","journal-title":"Am. J. Physiol. Ren. Physiol."},{"key":"10.1016\/j.intimp.2026.117238_bb0630","article-title":"Autophagy-dependent ferroptosis in kidney disease","volume":"9","author":"Yang","year":"2022","journal-title":"Front Med (Lausanne)"},{"key":"10.1016\/j.intimp.2026.117238_bb0635","article-title":"Mechanisms of ferroptosis in chronic kidney disease","volume":"9-2022","author":"Zhuo","year":"2022","journal-title":"Front. Mol. Biosci."},{"issue":"15","key":"10.1016\/j.intimp.2026.117238_bb0640","doi-asserted-by":"crossref","DOI":"10.3390\/ijms26157441","article-title":"TMAO activates the NLRP3 Inflammasome, disrupts gut-kidney interaction, and promotes intestinal inflammation","volume":"26","author":"Fang","year":"2025","journal-title":"Int. J. Mol. Sci."},{"issue":"9","key":"10.1016\/j.intimp.2026.117238_bb0645","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0108448","article-title":"Podocyte injury caused by indoxyl sulfate, a uremic toxin and aryl-hydrocarbon receptor ligand","volume":"9","author":"Ichii","year":"2014","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.intimp.2026.117238_bb0650","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2011.29","article-title":"Calpain-mediated cleavage of Beclin-1 and autophagy deregulation following retinal ischemic injury in vivo","volume":"2","author":"Russo","year":"2011","journal-title":"Cell Death Dis."},{"issue":"1","key":"10.1016\/j.intimp.2026.117238_bb0655","doi-asserted-by":"crossref","DOI":"10.3390\/biom10010100","article-title":"Autophagy function and regulation in kidney disease","volume":"10","author":"Kaushal","year":"2020","journal-title":"Biomolecules"},{"issue":"2","key":"10.1016\/j.intimp.2026.117238_bb0660","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1042\/BCJ20240569","article-title":"Inhibition of RIPK1 or RIPK3 kinase activity post ischemia-reperfusion reduces the development of chronic kidney injury","volume":"482","author":"Pefanis","year":"2025","journal-title":"Biochem. J."},{"key":"10.1016\/j.intimp.2026.117238_bb0665","article-title":"The microbial metabolite trimethylamine N-oxide and the kidney diseases","volume":"15-2025","author":"Su","year":"2025","journal-title":"Front. Cell. Infect. Microbiol."},{"issue":"6036","key":"10.1016\/j.intimp.2026.117238_bb0670","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1126\/science.1204592","article-title":"TFEB links autophagy to lysosomal biogenesis","volume":"332","author":"Settembre","year":"2011","journal-title":"Science"},{"issue":"4","key":"10.1016\/j.intimp.2026.117238_bb0675","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1097\/MNH.0000000000000616","article-title":"Molecular regulation and function of FoxO3 in chronic kidney disease","volume":"29","author":"Lin","year":"2020","journal-title":"Curr. Opin. Nephrol. Hypertens."},{"issue":"14","key":"10.1016\/j.intimp.2026.117238_bb0680","doi-asserted-by":"crossref","first-page":"1692","DOI":"10.1097\/CM9.0000000000002295","article-title":"Epigenetic connection between gut microbiota-derived short-chain fatty acids and chromatin histone modification in kidney diseases","volume":"135","author":"Li","year":"2022","journal-title":"Chin. Med. J."},{"issue":"1","key":"10.1016\/j.intimp.2026.117238_bb0685","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1038\/s41420-023-01399-w","article-title":"The role of HDAC3 and its inhibitors in regulation of oxidative stress and chronic diseases","volume":"9","author":"He","year":"2023","journal-title":"Cell Death Discov."},{"issue":"5","key":"10.1016\/j.intimp.2026.117238_bb0690","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.7150\/ijbs.91480","article-title":"Impaired TFEB-mediated autophagy-lysosome fusion promotes tubular cell cycle G2\/M arrest and renal fibrosis by suppressing ATP6V0C expression and interacting with SNAREs","volume":"20","author":"Ren","year":"2024","journal-title":"Int. J. Biol. Sci."},{"issue":"5","key":"10.1016\/j.intimp.2026.117238_bb0695","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1007\/s10157-016-1365-6","article-title":"Valproic acid attenuates renal fibrosis through the induction of autophagy","volume":"21","author":"Kawaoka","year":"2017","journal-title":"Clin. Exp. Nephrol."},{"issue":"Database issue","key":"10.1016\/j.intimp.2026.117238_bb0700","doi-asserted-by":"crossref","first-page":"D521","DOI":"10.1093\/nar\/gkl923","article-title":"HMDB: the human metabolome database","volume":"35","author":"Wishart","year":"2007","journal-title":"Nucleic Acids Res."},{"issue":"5","key":"10.1016\/j.intimp.2026.117238_bb0705","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.cmet.2007.10.005","article-title":"Metabolomics","volume":"6","author":"Idle","year":"2007","journal-title":"Cell Metab."},{"key":"10.1016\/j.intimp.2026.117238_bb0710","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbpa.2023.102400","article-title":"Nutritional metabolomics: recent developments and future needs","volume":"77","author":"Kortesniemi","year":"2023","journal-title":"Curr. Opin. Chem. Biol."},{"issue":"1","key":"10.1016\/j.intimp.2026.117238_bb0715","doi-asserted-by":"crossref","DOI":"10.1101\/mcs.a000588","article-title":"Metabolomics: an emerging but powerful tool for precision medicine","volume":"1","author":"Clish","year":"2015","journal-title":"Cold Spring Harb Mol Case Stud"},{"issue":"5","key":"10.1016\/j.intimp.2026.117238_bb0720","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/nrneph.2017.30","article-title":"Metabolomics for clinical use and research in chronic kidney disease","volume":"13","author":"Hocher","year":"2017","journal-title":"Nat. Rev. Nephrol."},{"key":"10.1016\/j.intimp.2026.117238_bb0725","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1007\/978-1-4939-7172-5_13","article-title":"NMR and MS methods for metabolomics","volume":"1641","author":"Amberg","year":"2017","journal-title":"Methods Mol. Biol."},{"issue":"7","key":"10.1016\/j.intimp.2026.117238_bb0730","doi-asserted-by":"crossref","DOI":"10.3390\/metabo9070123","article-title":"NMR spectroscopy for metabolomics research","volume":"9","author":"Emwas","year":"2019","journal-title":"Metabolites"},{"issue":"1","key":"10.1016\/j.intimp.2026.117238_bb0735","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1515\/tjb-2023-0095","article-title":"Metabolomics: a review of liquid chromatography mass spectrometry-based methods and clinical applications","volume":"49","author":"Do\u011fan","year":"2024","journal-title":"Turk. J. Biochem."},{"key":"10.1016\/j.intimp.2026.117238_bb0740","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.jpba.2017.07.044","article-title":"Quality assurance procedures for mass spectrometry untargeted metabolomics. A review","volume":"147","author":"Dudzik","year":"2018","journal-title":"J. Pharm. Biomed. Anal."},{"issue":"10","key":"10.1016\/j.intimp.2026.117238_bb0745","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23105354","article-title":"Short-chain fatty acids in chronic kidney disease: focus on inflammation and oxidative stress regulation","volume":"23","author":"Magliocca","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.intimp.2026.117238_bb0750","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.1080456","article-title":"The role and mechanism of gut microbiota-derived short-chain fatty in the prevention and treatment of diabetic kidney disease","volume":"13","author":"Tao","year":"2022","journal-title":"Front. Immunol."},{"issue":"2","key":"10.1016\/j.intimp.2026.117238_bb0755","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1038\/s41401-022-00947-x","article-title":"Integrative phosphatidylcholine metabolism through phospholipase a(2) in rats with chronic kidney disease","volume":"44","author":"Wang","year":"2023","journal-title":"Acta Pharmacol. Sin."},{"issue":"5","key":"10.1016\/j.intimp.2026.117238_bb0760","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1038\/aps.2013.186","article-title":"Cordyceps sinensis protects against liver and heart injuries in a rat model of chronic kidney disease: a metabolomic analysis","volume":"35","author":"Liu","year":"2014","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.intimp.2026.117238_bb0765","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.969930","article-title":"Membranous nephropathy: systems biology-based novel mechanism and traditional Chinese medicine therapy","volume":"13","author":"Miao","year":"2022","journal-title":"Front. Pharmacol."},{"issue":"11","key":"10.1016\/j.intimp.2026.117238_bb0770","doi-asserted-by":"crossref","first-page":"2929","DOI":"10.1038\/s41401-022-00914-6","article-title":"Intrarenal 1-methoxypyrene, an aryl hydrocarbon receptor agonist, mediates progressive tubulointerstitial fibrosis in mice","volume":"43","author":"Cao","year":"2022","journal-title":"Acta Pharmacol. Sin."},{"issue":"6","key":"10.1016\/j.intimp.2026.117238_bb0775","doi-asserted-by":"crossref","DOI":"10.1016\/j.semnephrol.2025.151579","article-title":"Pathology of chronic kidney disease and spatial metabolomics","volume":"44","author":"Hodgin","year":"2024","journal-title":"Semin. Nephrol."},{"issue":"12","key":"10.1016\/j.intimp.2026.117238_bb0780","doi-asserted-by":"crossref","first-page":"4601","DOI":"10.7150\/ijbs.91751","article-title":"Dissection of targeting molecular mechanisms of Celastrol-induced nephrotoxicity via a combined deconvolution strategy of Chemoproteomics and metabolomics","volume":"20","author":"Liu","year":"2024","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.intimp.2026.117238_bb0785","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2023.101861","article-title":"Deciphering the role of lipoproteins and lipid metabolic alterations in ageing and ageing-associated renal fibrosis","volume":"85","author":"Liu","year":"2023","journal-title":"Ageing Res. Rev."},{"issue":"17","key":"10.1016\/j.intimp.2026.117238_bb0790","doi-asserted-by":"crossref","first-page":"4344","DOI":"10.1111\/bph.15856","article-title":"Metabolomics analysis of human plasma reveals decreased production of trimethylamine N-oxide retards the progression of chronic kidney disease","volume":"179","author":"Hu","year":"2022","journal-title":"Br. J. Pharmacol."},{"issue":"3","key":"10.1016\/j.intimp.2026.117238_bb0795","doi-asserted-by":"crossref","DOI":"10.1016\/j.beem.2021.101484","article-title":"Intestinal microbiota and diabetic kidney diseases: the role of microbiota and derived metabolites inmodulation of renal inflammation and disease progression","volume":"35","author":"Mosterd","year":"2021","journal-title":"Best Pract. Res. Clin. Endocrinol. Metab."},{"issue":"20","key":"10.1016\/j.intimp.2026.117238_bb0800","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1016\/j.jchromb.2009.11.040","article-title":"Metabolomic analysis of uremic toxins by liquid chromatography\/electrospray ionization-tandem mass spectrometry","volume":"878","author":"Kikuchi","year":"2010","journal-title":"J. Chromatogr. B Anal. Technol. Biomed. Life Sci."},{"issue":"Spec Iss","key":"10.1016\/j.intimp.2026.117238_bb0805","first-page":"S0017","article-title":"Correlation between serum levels of protein-bound uremic toxins in hemodialysis patients measured by LC\/MS\/MS","volume":"2","author":"Itoh","year":"2013","journal-title":"Mass Spectrom."},{"issue":"3","key":"10.1016\/j.intimp.2026.117238_bb0810","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1093\/ndt\/gfq580","article-title":"P-Cresyl sulphate and indoxyl sulphate predict progression of chronic kidney disease","volume":"26","author":"Wu","year":"2011","journal-title":"Nephrol. Dial. Transplant."},{"issue":"7","key":"10.1016\/j.intimp.2026.117238_bb0815","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0132589","article-title":"Meta-analysis of the associations of p-Cresyl sulfate (PCS) and Indoxyl sulfate (IS) with cardiovascular events and all-cause mortality in patients with chronic renal failure","volume":"10","author":"Lin","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.intimp.2026.117238_bb0820","doi-asserted-by":"crossref","first-page":"1675458","DOI":"10.3389\/fmed.2025.1675458","article-title":"The gut-kidney axis in chronic kidney disease: mechanisms, microbial metabolites, and microbiome-targeted therapeutics","volume":"12","author":"Alobaidi","year":"2025","journal-title":"Front Med (Lausanne)"},{"issue":"3","key":"10.1016\/j.intimp.2026.117238_bb0825","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1161\/CIRCRESAHA.116.305360","article-title":"Gut microbiota-dependent trimethylamine N-oxide (TMAO) pathway contributes to both development of renal insufficiency and mortality risk in chronic kidney disease","volume":"116","author":"Tang","year":"2015","journal-title":"Circ. Res."},{"key":"10.1016\/j.intimp.2026.117238_bb0830","article-title":"Circulating trimethylamine-N-oxide and risk of all-cause and cardiovascular mortality in patients with chronic kidney disease: a systematic review and meta-analysis","volume":"9-2022","author":"Zhou","year":"2022","journal-title":"Front. Med."},{"key":"10.1016\/j.intimp.2026.117238_bb0835","article-title":"Impaired renal function and dysbiosis of gut microbiota contribute to increased trimethylamine-N-oxide in chronic kidney disease patients","volume":"7","author":"Xu","year":"2017","journal-title":"Sci. Rep."},{"issue":"5","key":"10.1016\/j.intimp.2026.117238_bb0840","doi-asserted-by":"crossref","DOI":"10.1042\/BSR20232090","article-title":"Association of the trimethylamine N-oxide with cardiovascular risk and vascular alterations in middle-aged patients with risk factors for cardiovascular diseases","volume":"44","author":"Spasova","year":"2024","journal-title":"Biosci. Rep."},{"issue":"20","key":"10.1016\/j.intimp.2026.117238_bb0845","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.161696","article-title":"Metabolite profiling of CKD progression in the chronic renal insufficiency cohort study","volume":"7","author":"Wen","year":"2022","journal-title":"JCI Insight"},{"issue":"5","key":"10.1016\/j.intimp.2026.117238_bb0850","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1039\/D5MO00019J","article-title":"Understanding metabolic alterations in advanced stage chronic kidney disease patients by NMR-based metabolomics","volume":"21","author":"Sahu","year":"2025","journal-title":"Molecular Omics"},{"issue":"9","key":"10.1016\/j.intimp.2026.117238_bb0855","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1038\/hr.2010.113","article-title":"Metabolomic profiling of uremic solutes in CKD patients","volume":"33","author":"Toyohara","year":"2010","journal-title":"Hypertens. Res."},{"issue":"1","key":"10.1016\/j.intimp.2026.117238_bb0860","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-023-33377-8","article-title":"Metabolomics profiling distinctively identified end-stage renal disease patients from chronic kidney disease patients","volume":"13","author":"Dahabiyeh","year":"2023","journal-title":"Sci. Rep."},{"issue":"5","key":"10.1016\/j.intimp.2026.117238_bb0865","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1159\/000446484","article-title":"Metabolomics of chronic kidney disease progression: a case-control analysis in the chronic renal insufficiency cohort study","volume":"43","author":"Rhee","year":"2016","journal-title":"Am. J. Nephrol."},{"issue":"1","key":"10.1016\/j.intimp.2026.117238_bb0870","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1053\/j.ajkd.2023.11.013","article-title":"Metabolites associated with uremic symptoms in patients with CKD: findings from the chronic renal insufficiency cohort (CRIC) study","volume":"84","author":"Wulczyn","year":"2024","journal-title":"Am. J. Kidney Dis."},{"key":"10.1016\/j.intimp.2026.117238_bb0875","article-title":"Metabolomics evaluation of patients with stage 5 chronic kidney disease before dialysis, maintenance hemodialysis, and peritoneal dialysis","volume":"11","author":"Zhu","year":"2020","journal-title":"Front. Physiol."},{"issue":"20","key":"10.1016\/j.intimp.2026.117238_bb0880","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.161696","article-title":"Metabolite profiling of CKD progression in the chronic renal insufficiency cohort study","volume":"7","author":"Wen","year":"2022","journal-title":"JCI Insight"},{"issue":"1","key":"10.1016\/j.intimp.2026.117238_bb0885","doi-asserted-by":"crossref","DOI":"10.3390\/toxins10010033","article-title":"Biochemical and clinical impact of organic uremic retention solutes: a comprehensive update","volume":"10","author":"Vanholder","year":"2018","journal-title":"Toxins (Basel)"},{"issue":"2","key":"10.1016\/j.intimp.2026.117238_bb0890","doi-asserted-by":"crossref","DOI":"10.1080\/0886022X.2024.2409346","article-title":"Identification of serum biomarkers for chronic kidney disease using serum metabolomics","volume":"46","author":"Gu","year":"2024","journal-title":"Ren. Fail."},{"issue":"1","key":"10.1016\/j.intimp.2026.117238_bb0895","doi-asserted-by":"crossref","DOI":"10.3390\/metabo11010045","article-title":"Tissue-specific (1)H-NMR Metabolomic profiling in mice with adenine-induced chronic kidney disease","volume":"11","author":"Khattri","year":"2021","journal-title":"Metabolites"},{"issue":"2","key":"10.1016\/j.intimp.2026.117238_bb0900","article-title":"Metabolomic profiling of adenine-induced CKD: pathway interconnections and kidney injury","volume":"14","author":"Li","year":"2025","journal-title":"Toxicol. Res."},{"issue":"2","key":"10.1016\/j.intimp.2026.117238_bb0905","article-title":"Metabolomic profiling of adenine-induced CKD: pathway interconnections and kidney injury","volume":"14","author":"Li","year":"2025","journal-title":"Toxicol Res (Camb)"},{"issue":"8","key":"10.1016\/j.intimp.2026.117238_bb0910","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1681\/ASN.2012101006","article-title":"A combined epidemiologic and metabolomic approach improves CKD prediction","volume":"24","author":"Rhee","year":"2013","journal-title":"J. Am. Soc. Nephrol."},{"issue":"11","key":"10.1016\/j.intimp.2026.117238_bb0915","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1681\/ASN.2013020126","article-title":"Metabolomics reveals signature of mitochondrial dysfunction in diabetic kidney disease","volume":"24","author":"Sharma","year":"2013","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.intimp.2026.117238_bb0920","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.trsl.2016.04.007","article-title":"Gut microbiome in chronic kidney disease: challenges and opportunities","volume":"179","author":"Nallu","year":"2017","journal-title":"Transl. Res."},{"issue":"4","key":"10.1016\/j.intimp.2026.117238_bb0925","doi-asserted-by":"crossref","DOI":"10.3390\/toxins13040252","article-title":"The impact of CKD on uremic toxins and gut microbiota","volume":"13","author":"Rysz","year":"2021","journal-title":"Toxins"},{"issue":"3","key":"10.1016\/j.intimp.2026.117238_bb0930","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1038\/s41419-018-0374-7","article-title":"Histone deacetylase inhibitors protect against cisplatin-induced acute kidney injury by activating autophagy in proximal tubular cells","volume":"9","author":"Liu","year":"2018","journal-title":"Cell Death Dis."},{"issue":"12","key":"10.1016\/j.intimp.2026.117238_bb0935","doi-asserted-by":"crossref","DOI":"10.3390\/toxins13120909","article-title":"Indoxyl sulfate contributes to mTORC1-induced renal fibrosis via the OAT\/NADPH oxidase\/ROS pathway","volume":"13","author":"Nakano","year":"2021","journal-title":"Toxins (Basel)"},{"issue":"5","key":"10.1016\/j.intimp.2026.117238_bb0940","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/nrneph.2017.30","article-title":"Metabolomics for clinical use and research in chronic kidney disease","volume":"13","author":"Hocher","year":"2017","journal-title":"Nat. Rev. Nephrol."},{"issue":"3","key":"10.1016\/j.intimp.2026.117238_bb0945","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1161\/CIRCRESAHA.116.305360","article-title":"Gut microbiota-dependent trimethylamine N-oxide (TMAO) pathway contributes to both development of renal insufficiency and mortality risk in chronic kidney disease","volume":"116","author":"Tang","year":"2015","journal-title":"Circ. Res."},{"key":"10.1016\/j.intimp.2026.117238_bb0950","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.ebiom.2017.10.027","article-title":"Metabolomics and gene expression analysis reveal Down-regulation of the citric acid (TCA) cycle in non-diabetic CKD patients","volume":"26","author":"Hallan","year":"2017","journal-title":"EBioMedicine"},{"issue":"3","key":"10.1016\/j.intimp.2026.117238_bb0955","doi-asserted-by":"crossref","first-page":"404","DOI":"10.2215\/CJN.07420619","article-title":"Proteomics and metabolomics in kidney disease, including insights into etiology, treatment, and prevention","volume":"15","author":"Dubin","year":"2020","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"10.1016\/j.intimp.2026.117238_bb0960","article-title":"Transformation of acute kidney injury to chronic kidney disease: the interaction between mitophagy and NLRP3 inflammasome","volume":"12-2025","author":"Zhu","year":"2025","journal-title":"Front. Mol. Biosci."},{"issue":"4","key":"10.1016\/j.intimp.2026.117238_bb0965","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1172\/JCI39492","article-title":"Autophagy influences glomerular disease susceptibility and maintains podocyte homeostasis in aging mice","volume":"120","author":"Hartleben","year":"2010","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.intimp.2026.117238_bb0970","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2024.105294","article-title":"Renal tubular epithelial cells response to injury in acute kidney injury","volume":"107","author":"Li","year":"2024","journal-title":"eBioMedicine"},{"issue":"6","key":"10.1016\/j.intimp.2026.117238_bb0975","doi-asserted-by":"crossref","first-page":"F1211","DOI":"10.1152\/ajprenal.00298.2018","article-title":"Chronic kidney disease and the gut microbiome","volume":"316","author":"Hobby","year":"2019","journal-title":"American Journal of Physiology-Renal Physiology"},{"issue":"6","key":"10.1016\/j.intimp.2026.117238_bb0980","doi-asserted-by":"crossref","DOI":"10.3390\/antiox13060687","article-title":"Role of uremic toxins, oxidative stress, and renal fibrosis in chronic kidney disease","volume":"13","author":"Fr\u0105k","year":"2024","journal-title":"Antioxidants"},{"issue":"12","key":"10.1016\/j.intimp.2026.117238_bb0985","doi-asserted-by":"crossref","DOI":"10.3390\/microorganisms8121862","article-title":"Chronic kidney disease, gut Dysbiosis, and constipation: a burdensome triplet","volume":"8","author":"Ikee","year":"2020","journal-title":"Microorganisms"},{"issue":"1","key":"10.1016\/j.intimp.2026.117238_bb0990","doi-asserted-by":"crossref","first-page":"F106","DOI":"10.1152\/ajprenal.00117.2021","article-title":"Skeletal myopathy in CKD: a comparison of adenine-induced nephropathy and 5\/6 nephrectomy models in mice","volume":"321","author":"Kim","year":"2021","journal-title":"Am. J. Physiol. Ren. Physiol."},{"issue":"1","key":"10.1016\/j.intimp.2026.117238_bb0995","doi-asserted-by":"crossref","first-page":"88","DOI":"10.3390\/cells12010088","article-title":"Oxidative stress and mitochondrial dysfunction in chronic kidney disease","volume":"12","author":"Ho","year":"2023","journal-title":"Cells"},{"issue":"10","key":"10.1016\/j.intimp.2026.117238_bb1000","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines12102203","article-title":"Chronic kidney disease progression-a challenge","volume":"12","author":"Maringhini","year":"2024","journal-title":"Biomedicines"},{"issue":"6","key":"10.1016\/j.intimp.2026.117238_bb1005","doi-asserted-by":"crossref","first-page":"S30","DOI":"10.1053\/j.jrn.2022.12.004","article-title":"Targeting the gut microbiota in kidney disease: the future in renal nutrition and metabolism","volume":"33","author":"Lambert","year":"2023","journal-title":"J. Ren. Nutr."},{"issue":"1","key":"10.1016\/j.intimp.2026.117238_bb1010","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1186\/s12882-020-01805-w","article-title":"The gut microbiota profile of adults with kidney disease and kidney stones: a systematic review of the literature","volume":"21","author":"Stanford","year":"2020","journal-title":"BMC Nephrol."},{"issue":"7","key":"10.1016\/j.intimp.2026.117238_bb1015","doi-asserted-by":"crossref","DOI":"10.3390\/toxins10070298","article-title":"Intestinal barrier function in chronic kidney disease","volume":"10","author":"Meijers","year":"2018","journal-title":"Toxins"},{"issue":"3","key":"10.1016\/j.intimp.2026.117238_bb1020","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1007\/s00467-025-06780-8","article-title":"Pediatric and adult point of view on the gut-kidney axis in CKD","volume":"41","author":"Holle","year":"2026","journal-title":"Pediatr. Nephrol."},{"issue":"10","key":"10.1016\/j.intimp.2026.117238_bb1025","first-page":"Cd013631","article-title":"Synbiotics, prebiotics and probiotics for people with chronic kidney disease","volume":"10","author":"Cooper","year":"2023","journal-title":"Cochrane Database Syst. Rev."},{"issue":"12","key":"10.1016\/j.intimp.2026.117238_bb1030","doi-asserted-by":"crossref","first-page":"5398","DOI":"10.7150\/thno.41725","article-title":"Integrative metagenomic and metabolomic analyses reveal severity-specific signatures of gut microbiota in chronic kidney disease","volume":"10","author":"Wu","year":"2020","journal-title":"Theranostics"}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576926010842?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576926010842?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T16:08:05Z","timestamp":1789142885000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576926010842"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":206,"alternative-id":["S1567576926010842"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2026.117238","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The gut-kidney axis revisited: Integrating gut microbiota, autophagy and metabolomics in chronic kidney disease","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2026.117238","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"117238"}}